Abstract:BACKGROUND:HeartModel (HM) is a fully automated adaptive quantification software that can quickly quantify left heart volume and left ventricular function. This study used HM to quantify the left ventricular end-diastolic (LVEDV) and end-systolic volumes (LVESV) of patients with dilated cardiomyopathy (DCM), coronary artery heart disease with segmental wall motion abnormality, and hypertrophic cardiomyopathy (HCM) to determine whether there were differences in the feasibility, accuracy, and repeatability of measuring the LVEDV, LVESV, LV ejection fraction (LVEF) and left atrial end-systolic volume (LAESV) and to compare these measurements with those obtained with traditional two-dimensional (2D) and three-dimensional (3D) methods.AIM:To evaluate the application value of HM in quantifying left heart chamber volume and LVEF in clinical patients.METHODS:A total of 150 subjects who underwent 2D and 3D echocardiography were divided into 4 groups: (1) 42 patients with normal heart shape and function (control group, Group A); (2) 35 patients with DCM (Group B); (3) 41 patients with LV remodeling after acute myocardial infarction (Group C); and (4) 32 patients with HCM (Group D). The LVEDV, LVESV, LVEF and LAESV obtained by HM with (HM-RE) and without regional endocardial border editing (HM-NE) were compared with those measured by traditional 2D/3D echocardiographic methods to assess the correlation, consistency, and repeatability of all methods.RESULTS:(1) The parameters measured by HM were significantly different among the groups (P < 0.05 for all). Compared with Groups A, C, and D, Group B had higher LVEDV and LVESV (P < 0.05 for all) and lower LVEF (P < 0.05 for all); (2) HM-NE overestimated LVEDV, LVESV, and LAESV with wide biases and underestimated LVEF with a small bias; contour adjustment reduced the biases and limits of agreement (bias: LVEDV, 28.17 mL, LVESV, 14.92 mL, LAESV, 8.18 mL, LVEF, -0.04%). The correlations between HM-RE and advanced cardiac 3D quantification (3DQA) (r s = 0.91-0.95, P < 0.05 for all) were higher than those between HM-NE (r s = 0.85-0.93, P < 0.05 for all) and the traditional 2D methods. The correlations between HM-RE and 3DQA were good for Groups A, B, and C but remained weak for Group D (LVEDV and LVESV, r s = 0.48-0.54, P < 0.05 for all); and (3) The intraobserver and interobserver variability for the HM-RE measurements were low.CONCLUSION:HM can be used to quantify the LV volume and LVEF in patients with common heart diseases and sufficient image quality. HM with contour editing is highly reproducible and accurate and may be recommended for clinical practice.

Assessment of segmental left ventricular function in hypertrophic cardiomyopathy patients by two-dimensional strain

Evaluation of Left Ventricular Global and Regional Systolic Function in Patients with Hypertrophic Cardiomyopathy by the Real Time 3-Dimensional Speckle Tracing Imaging

Assessment of Left Atrial Strain in Patients Pre-and Post-Mitral Valvuloplasty by Using Two-Dimensional Speckle Tracking Echocardiography

Three-dimensional Echocardiographic Assessment of Left Ventricular Volume in Different Heart Diseases Using a Fully Automated Quantification Software.

Evaluation of regional myocardial systolic function of left ventricular in hypertrophic cardiomyopathy using ultrasound speckle tracking imaging

Evaluation of left ventricular myocardial strain of patients with hypertrophic cardiomyopathy using cardiac magnetic resonance imaging

Quantitative Assessment of Ischemic Myocardial Systolic Function in Patients with Coronary Heart Disease Using Strain Imaging

[Evaluation of Strain Indexes and Prognosis of Patients with Cardiac Amyloidosis with Preserved LVEF by Three-Dimensional Speckle Tracking Imaging].

Evaluation of regional myocardial function in hypertrophic cardiomyopathy patients and healthy persons by strain imaging

Application of quantitative tissue velocity imaging in percutaneous transluminal septal myocardial ablation of hypertrophic obstructive cardiomyopathy

The Evaluation of Right Ventricular Function of Hypertrophic Cardiomyopathy Using Two Dimensional Strain Imaging

Real-time three-dimensional echocardiographic quantification of left ventricular systolic synchronicity in patients with dilated cardiomyopathy

Clinical Study on Assessment of Left Ventricular Systolic Function in Patients with Hypertrophic Cardiomyopathy by Vector Velocity Imaging

Evaluation of left ventricular function with heart failure by two-dimensional strain echocardiography

Quantification of left atrial function in patients with atrial fibrillation using strain imaging

Reduction of Left Ventricular Longitudinal Global and Segmental Systolic Functions in Patients with Hypertrophic Cardiomyopathy: Study of Two-Dimensional Tissue Motion Annular Displacement.

Evaluation of diastolic function of hypertrophic cardiomyopathy using left ventricular volume-time curve

Evaluation of twist function of left ventricle using speckle tracking imaging

Assessment of Left Ventricular Regional and Global Systolic Function in Patients with Coronary Artery Disease Using Strain Parameter of Velocity Vector Imaging

Evaluation of Left Ventricular Contraction Pattern and Function with Area Strain

Speckle Tracking Imaging Assessment of Left Ventricular Torsion in Patients with Hypertrophic Cardiomyopathy